Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib pilot study in chronic antibiotic-dependent or refractory idiopathic pouchitis
2021-005694-87Phase 4Completed
- Sponsor
- University College Dublin
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tofacitinib in pouchitis and autoimmune colitis (2 arms), sponsored by University College Dublin. Primary endpoint: Endoscopic response. Started Oct 2021; status: completed.
02
Drugs
03
Conditions
pouchitisautoimmune colitis
Beyond the preview
Go deeper on 2021-005694-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005694-87.